Granted Patent
S1
US 1,060,669 · App. 29/686,956 · Granted Feb 4, 2025
Tether for a capsule endoscope
Assignee:
AnX Robotica Corp
View Patent ↗
Loading inventors, assignments & file history…
Claims (1)
The ornamental design for a tether for a capsule endoscope as shown and described.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 9, 2019
From: DUAN, XIAODONG
To: ANX ROBOTICA CORP
Reel/Frame 048837/0832 →
References Cited (105)
US 4195624A
· Douglas
· 1980
[cited by applicant]
US 4198960A
· Utsugi
· 1980
[cited by applicant]
US 5653677A
· Okada et al.
· 1997
[cited by applicant]
US 5840251A
· Iwak
· 1998
[cited by applicant]
US D501549S
· McAllister
· 2005
[cited by examiner]
US D560813S
· Matsuura
· 2008
[cited by examiner]
US D636071S
· Bhatt
· 2011
[cited by examiner]
US 8235888B2
· Kawano
· 2012
[cited by applicant]
US 8269823B2
· Hirakawa et al.
· 2012
[cited by applicant]
US D747791S
· Kaser
· 2016
[cited by examiner]
US 9339174B2
· Gilad et al.
· 2016
[cited by applicant]
US 9392929B2
· Bendele et al.
· 2016
[cited by applicant]
US D827816S
· Newman
· 2018
[cited by examiner]
US D891632S
· Shalon
· 2020
[cited by examiner]
US 20030013938A1
· Iddan et al.
· 2003
[cited by applicant]
US 20060193893A1
· Brown
· 2006
[cited by applicant]
US 20070049796A1
· Fujikura
· 2007
[cited by applicant]
US 20080015413A1
· Barlow et al.
· 2008
[cited by applicant]
US 20080108866A1
· Lin
· 2008
[cited by examiner]
US 20080154093A1
· Cho et al.
· 2008
[cited by applicant]
US 20080167525A1
· Wakefield
· 2008
[cited by applicant]
US 20080177141A1
· Wu et al.
· 2008
[cited by applicant]
US 20090018396A1
· Takizawa et al.
· 2009
[cited by applicant]
US 20090018398A1
· Segawa
· 2009
[cited by examiner]
US 20090062614A1
· Adzich et al.
· 2009
[cited by applicant]
US 20100322866A1
· Rabinovitz
· 2010
[cited by applicant]
US 20110144431A1
· Graumann
· 2011
[cited by examiner]
US 20110184293A1
· Rabinovitz et al.
· 2011
[cited by applicant]
US 20120101331A1
· Gilad et al.
· 2012
[cited by applicant]
US 20120165796A1
· Ortiz et al.
· 2012
[cited by applicant]
US 20140243598A1
· Genier et al.
· 2014
[cited by applicant]
US 20160235282A1
· Nakamura
· 2016
[cited by applicant]
US 20200323433A1
· Ming
· 2020
[cited by examiner]
US 20240000300A1
· Duar
· 2024
[cited by applicant]
CN 103113606A
· 2013
[cited by applicant]
CN 103304832A
· 2013
[cited by applicant]
CN 107064131A
· 2017
[cited by applicant]
CN 109813666A
· 2019
[cited by applicant]
CN 109924937A
· 2019
[cited by applicant]
CN 111202528A
· 2020
[cited by applicant]
CN 111808916A
· 2020
[cited by applicant]
WO WO2019171409A1
· 2019
[cited by applicant]
Anx Robotics Colon Capsule System, posted at anxrobotics.com, first date unavailable, retrieved Jul. 11, 2023, online, URL: https://www.anxrobotics.com/products/navicam-colon-capsule-system/ (Year: 2023).
[cited by examiner]
Chen, R. et al. (2006). “Quantitative Proteomic Profiling of Pancreatic Cancer Juice,” Proteomics 6:3871-3879.
[cited by applicant]
Chinese Office Action mailed on Jun. 10, 2022, for Application No. 202010725938.5, filed on Jul. 23, 2021, 14 total pages (with English Translation).
[cited by applicant]
Eshleman, J.R. et al. (2015). “KRAS and Guanine Nucleotide-Binding Protein Mutations in Pancreatic Juice Collected from the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound.” Clinical Gas…
[cited by applicant]
Extended European Search Report mailed on Dec. 5, 2022, for EP Application No. 20 787 566.7, filed on Apr. 9, 2020, 8 pages.
[cited by applicant]
Farrell, J.J. et al. (2005). “Early Detection Markers in Pancreas Cancer,” Cancer Biomarkers 1:157-175.
[cited by applicant]
Final Office Action mailed on Jul. 28, 2022, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 12 pages.
[cited by applicant]
Fujiyama, Y. et al. (2020). “Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN),” Annals of Surgical Oncology 27:4007-4016.
[cited by applicant]
Hayakawa, H. et al. (2019). “Carcinoembryonic Antigen Level in the Pancreatic Juice Is Effective in Malignancy Diagnosis and Prediction of Future Malignant Transformation of Intraductal Papillary Mucinous Neoplasm of th…
[cited by applicant]
International Search Report mailed on Aug. 19, 2020, for PCT Application No. PCT/US2020/027422, filed on Apr. 9, 2020, 4 pages.
[cited by applicant]
International Search Report mailed on Oct. 20, 2021, for PCT Application No. PCT/US2021/108258, filed on Jul. 23, 2021, 7 pages (with English Translation).
[cited by applicant]
Majumder, S. et al. (2020). “Methylated DNA in Pancreatic Juice Distinguishes Patients with Pancreatic Cancer from Controls,” Clinical Gastroenterology and Hepatology 18:676-683.e3.
[cited by applicant]
Majumder, S. et al. (2019). “Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing,” The American Journal of Gastroenterology 114:1…
[cited by applicant]
Mori, Y. et al. (2013). “A Minimally Invasive and Simple Screening Test for Detection of Pancreatic Ductal Adenocarcinoma Using Biomarkers in Duodenal Juice,” Pancreas 42:187-192.
[cited by applicant]
Nakamura, S. et al. (2019). “Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma,” Annals of Surgical Oncology 26:2104-2111.
[cited by applicant]
Nakashima, A. et al. (2009). “Usefulness of Human Telomerase Reverse Transcriptase in Pancreatic Juice as a Biomarker of Pancreatic Malignancy,” Pancreas 38:527-533.
[cited by applicant]
Non-Final Office Action mailed on Jan. 31, 2022, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 11 pages.
[cited by applicant]
Non-Final Office Action mailed on Sep. 6, 2022, for U.S. Appl. No. 17/384,101, filed Jul. 23, 2021, 11 pages.
[cited by applicant]
Non-Final Office Action mailed on Jan. 23, 2023, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 12 pages.
[cited by applicant]
Non-Final Office Action mailed on Feb. 6, 2023, for U.S. Appl. No. 17/384,101, filed Jul. 23, 2021, 13 pages.
[cited by applicant]
Singhi, A.D et al. (2018). “Preoperative Next-Generation Sequencing of Pancreatic Cyst Fluid Is Highly Accurate in Cyst Classification and Detection of Advanced Neoplasia,” Gut 67:2131-2141.
[cited by applicant]
Springer, S. et al. (2015). “A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts,” Gastroenterology 149:1501-1510.
[cited by applicant]
Tanaka, M. et al. (2019). “Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review,” Clinical Gastroenterology and Hepatology 17:2199-2211.e21.
[cited by applicant]
Tian, T. et al. (2017). “Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies,” Oxidative Medicine and Cellular Longevity 2017:4535194.
[cited by applicant]
Tobi, M. et al. (2013). “Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma,” Digestive Diseases and Sciences 58:744-750.
[cited by applicant]
Wang, J. et al. (2014). “Circulating MicroRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer,” Journal of Cancer 5:696-705.
[cited by applicant]
Written Opinion of the International Searching Authority mailed on Aug. 19, 2020, for PCT Application No. PCT/US2020/027422, filed on Apr. 9, 2020, 9 pages.
[cited by applicant]
Yu, J. et al. (2017). “Digital Next-Generation Sequencing Identifies Low-Abundance Mutations in Pancreatic Juice Samples Collected from the Duodenum of Patients with Pancreatic Cancer and Intraductal Papillary Mucinous …
[cited by applicant]
Zhao, X.-R. et al. (2016). “Highly sensitive fluorescence detection of trypsin based on gold nanoparticle probes,” Anal. Methods 8:393-400.
[cited by applicant]
Notice of Allowance mailed on Aug. 10, 2023, for U.S. Appl. No. 16/844,248, filed Apr. 9, 2020, 7 pages.
[cited by applicant]
Notice of Allowance mailed on Jun. 8, 2023, for U.S. Appl. No. 17/384,101, filed Jul. 23, 2021, 8 pages.
[cited by applicant]